| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| IXICO Aktie jetzt für 0€ handeln | |||||
| 26.02. | IXICO validates automated brain imaging analysis platform | 5 | Investing.com | ||
| 26.02. | IXICO: Automatisierte Analyseplattform für Gehirnbilder übertrifft manuelle Verfahren | 5 | Investing.com Deutsch | ||
| 26.02. | IXICO plc - Validation of Neuroimaging Technology Platform | 4 | RNS | ||
| 12.02. | IXICO secures £1.5 million contract extension for Huntington's trial | 17 | Investing.com | ||
| 12.02. | IXICO sichert sich Vertragsverlängerung über 1,5 Millionen Pfund für Huntington-Studie | 17 | Investing.com Deutsch | ||
| 12.02. | IXICO plc - Correction: c.£1.5 million Contract Extension | 16 | RNS | ||
| 12.02. | IXICO plc - c.£1.5 million Contract Extension | 16 | RNS | ||
| 05.02. | IXICO plc - Appointment of Chief Commercial Officer | 16 | RNS | ||
| 23.01. | IXICO shareholders approve all resolutions at annual meeting | 17 | Investing.com | ||
| 23.01. | IXICO plc - Results of AGM | 17 | RNS | ||
| 09.12.25 | IXICO plc - Share option award | 16 | RNS | ||
| 09.12.25 | IXICO plc - Financial Results for year ended 30 September 2025 | 16 | RNS | ||
| 01.12.25 | Ixico strengthens scientific advisory board with two appointments | 17 | Sharecast | ||
| 01.12.25 | IXICO plc - Operational Update | 17 | RNS | ||
| 27.11.25 | IXICO to release full year 2025 results on December 9 | 17 | Investing.com | ||
| 27.11.25 | IXICO veröffentlicht Jahresergebnisse 2025 am 9. Dezember | 17 | Investing.com Deutsch | ||
| 27.11.25 | IXICO plc - Notice of 2025 Full Year Results and IMC | 16 | RNS | ||
| 17.11.25 | Ixico wins GBP3.7 million deal to support Huntington's Disease trial | 17 | Alliance News | ||
| 17.11.25 | AIM WINNERS & LOSERS: OptiBiotix and Ixico rise on deal wins | 18 | Alliance News | ||
| 17.11.25 | IXICO plc - Clinical Trial Contract Win | 16 | RNS |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 31,905 | -0,13 % | Eli Lilly und Novo Nordisk: Aktien nach Watsche von Analysten tief im Minus | Ein überraschender Kursrutsch erschüttert den Pharmariesen Eli Lilly, nachdem HSBC die Aktie auf "Reduce" herabgestuft hat. Die Analysten sehen das Kursniveau als zu ambitioniert und zweifeln an den... ► Artikel lesen | |
| AURORA CANNABIS | 2,855 | -0,87 % | K-Tech Solutions Company Limited Announces Joint Venture with Aurora AZ Energy Ltd. to Develop up to 500 MW of AI and HPC Infrastructure in Canada | HONG KONG and NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- K-Tech Solutions Company Limited (Nasdaq: KMRK) ("K-Tech" or the "Company"), a technology firm specializing in high-performance computing infrastructure... ► Artikel lesen | |
| CANOPY GROWTH | 0,827 | +0,85 % | Cannabis-Boom 2026: Warum Bioxyne und Canopy jetzt das Spielfeld in Deutschland besetzen | ||
| TILRAY BRANDS | 5,850 | +0,52 % | Tilray Brands, Inc.: Tilray Brands to Announce Third Quarter Fiscal Year 2026 Financial Results on April 1, 2026 | ||
| VERTEX PHARMACEUTICALS | 388,65 | -0,49 % | VERTEX PHARMACEUTICALS INC in ruhiger Marktstruktur | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | TAAT Global Alternatives Inc (2): TAAT Global CEO Saxon resigns | ||
| MPH HEALTH CARE | 17,950 | 0,00 % | Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH): Kaufen | Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH
21.11.2025 / 12:01 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer... ► Artikel lesen | |
| CRONOS GROUP | 2,180 | +1,87 % | Cronos Group Inc.: Cronos Group Reports 2025 Fourth Quarter and Full-Year Results | Net revenue in Q4 2025 increased by 47% year-over-year to $44.5 million; Net revenue in FY 2025 increased by 25% year-over-year to $146.6 million Achieved record net revenue in Q4 2025 and FY 2025... ► Artikel lesen | |
| SYNBIOTIC | 2,245 | +3,70 % | EQS-News: SYNBIOTIC SE: Globale Dynamik im Cannabismarkt: Neue Signale aus den USA stärken langfristige Perspektiven für Europa und SYNBIOTIC | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Marktbericht/Sonstiges
Globale Dynamik im Cannabismarkt: Neue Signale aus den USA stärken langfristige Perspektiven für Europa und SYNBIOTIC... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Announces Agreement to Extend Maturity Date for Convertible Debentures | Vancouver, British Columbia--(Newsfile Corp. - March 12, 2026) - Digicann Ventures Ltd. (CSE: DCNN.X) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the... ► Artikel lesen | |
| EYEPOINT | 10,645 | -2,11 % | EyePoint lawsuit accuses Ocular of 'malicious' defamation campaign in retina drug race | ||
| ORGANIGRAM GLOBAL | 1,120 | -4,27 % | Organigram Global Inc: Organigram garners ISS support for Sanity transaction | ||
| GREEN THUMB INDUSTRIES | 5,600 | -0,97 % | Green Thumb Industries Reports Fourth Quarter and Full Year 2025 Results | CHICAGO and VANCOUVER, British Columbia, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| SNDL | 1,148 | -2,96 % | SNDL Inc.: SNDL Reports Fourth Quarter and Full Year 2025 Financial and Operational Results | EDMONTON, Alberta, March 12, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) ("SNDL" or the "Company") reported its financial and operational results for the full year and fourth quarter... ► Artikel lesen | |
| SINOPHARM | 2,230 | +2,29 % | Reed Sinopharm Exhibitions (RSE): PCHi 2026: World's Largest Cosmetics Ingredients Exhibition Opens in Hangzhou | 860+ exhibitors from 26 countries and regions across 70,000 sqmClose to 50 new product launches, including global and China debuts295 product submissions and 19 engineer nominations for the... ► Artikel lesen |